Sign up to save your podcasts
Or
Share 278: Merger Mondays, Ozempic panic, & CRISPR'd pigs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
278: Merger Mondays, Ozempic panic, & CRISPR'd pigs
We discuss Bristol Myers Squibb’s multibillion-dollar acquisition of Mirati Therapeutics and what it means for a biotech sector still in a slump. We also explain the latest news in the life sciences, including Wall Street’s freakout over GLP-1, CRISPR’ing animals, and the latest in the NASH saga.
View all episodes
By STAT
4.5
309309 ratings
We discuss Bristol Myers Squibb’s multibillion-dollar acquisition of Mirati Therapeutics and what it means for a biotech sector still in a slump. We also explain the latest news in the life sciences, including Wall Street’s freakout over GLP-1, CRISPR’ing animals, and the latest in the NASH saga.
More shows like The Readout Loud
View all
Planet Money
30,734 Listeners
Odd Lots
1,942 Listeners
What the Health? From KFF Health News
493 Listeners
The Indicator from Planet Money
9,536 Listeners
The Journal.
6,074 Listeners
Tradeoffs
390 Listeners
Biotech 2050 Podcast
62 Listeners
Business Of Biotech
86 Listeners
BioCentury This Week
33 Listeners
Dwarkesh Podcast
523 Listeners
Hard Fork
5,510 Listeners
Biotech Hangout
20 Listeners
Ground Truths
51 Listeners
Money Stuff: The Podcast
392 Listeners
The BioCentury Show
12 Listeners